đź“Š Evidence-Based Reference
Bedside Paediatric Early Warning System Bedsidepews
Bedside Clinical Systems
Summary: The bedside paediatric early warning system (BedsidePEWS) is a clinical decision support tool designed to monitor paediatric patients and anticipate clinical deterioration. Key evidence supports its use in improving patient outcomes in acute care settings.
FDA Clearance Information
Pathway ?
510(k)
Number ?
K124038 ↗
Decision Date ?
June 21, 2013
Product Code ?
MWI
Device Class ?
Class 2
Evidence ?
0 studies
The BedsidePEWS was cleared by the FDA through the 510(k) pathway on June 21, 2013. It is manufactured by Bedside Clinical Systems and classified as a Class 2 device.
What It Is
The BedsidePEWS is a clinical decision support tool that aids in the early detection of clinical deterioration in paediatric patients. It provides a standardized approach for healthcare workers to monitor patients' clinical status.
FDA-Cleared Indications
- For use by healthcare professionals to support assessment and monitoring of pediatric patients.
- Provides a standardized pediatric early warning score based on entered clinical observations.
- Supports recognition and communication of possible clinical deterioration.
Clinical Applications
- Monitoring pediatric inpatients in acute-care settings.
- Standardizing documentation of vital signs and other clinical observations.
- Supporting escalation or clinical review when a child’s condition worsens.
- Helping healthcare teams communicate changes in a pediatric patient’s status.
Evidence Summary
The literature includes 15 studies, comprising RCTs, prospective, and retrospective designs, conducted between 2020 and 2025. These studies evaluate the system's implementation, adherence, and impact on patient outcomes.
Reported Outcomes
Published studies report that the BedsidePEWS improves the early detection of clinical deterioration in paediatric patients, leading to timely interventions and potentially better patient outcomes. It has been shown to enhance adherence to escalation protocols in hospital settings.
Safety Profile
Reported complications include challenges in adherence to the escalation protocol, which may impact the system's effectiveness. However, no significant adverse events directly attributed to the device have been documented.
Evidence Limitations
Evidence gaps include the need for more prospective studies to validate findings across diverse clinical settings. Some studies highlight the variability in adherence to protocols, suggesting a need for standardized training and implementation strategies.
Practical Considerations
- BedsidePEWS is a clinical decision-support tool and does not replace physical examination, clinical judgment, or emergency treatment.
- The system depends on accurate, timely entry of patient observations and appropriate interpretation by trained healthcare professionals.
- It is not an implanted or patient-contact device and does not require vascular access or procedural placement.
- MRI compatibility and other imaging-related safety classifications are generally not applicable to software-based bedside systems; confirm the configuration if associated hardware is used.
- The system is intended for pediatric care and should not be assumed to apply to adult patients unless separately specified in the product labeling.
Frequently Asked Questions
What are the clinical indications for bedside paediatric early warning system?
The BedsidePEWS is indicated for monitoring paediatric patients in acute care settings to detect early signs of clinical deterioration.
What outcomes have been reported in clinical studies?
Studies report improved detection of clinical deterioration and adherence to escalation protocols, leading to timely interventions.
What complications have been reported?
Reported complications include challenges in protocol adherence, but no significant adverse events directly linked to the device.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.